Metabolomics: Moving to the clinic

Journal of Neuroimmune Pharmacology

Volumn 5, Issue 1, 2010, Pages 4-17

  Nordström, Anders ^a   Lewensohn, Rolf ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Biomarkers; Cancer; Cardiovascular; Clinical; Mass spectrometry; Metabolite profiling; Metabolomics; Metabonomics; Neurology; NMR; Oncology; Pharmacology; Virology

Indexed keywords

BIOLOGICAL MARKER; CHLOROETHYLNITROSOUREA; MESSENGER RNA; PARACETAMOL; TRASTUZUMAB;

BREAST CANCER; CANCER DIAGNOSIS; CARDIOVASCULAR DISEASE; DIAGNOSTIC PROCEDURE; DRUG COST; DRUG TARGETING; HEART DISEASE; HUMAN; IMMUNOPATHOLOGY; MASS SPECTROMETRY; METABOLOMICS; NEOPLASM; NEUROLOGIC DISEASE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PHENOTYPE; PRIORITY JOURNAL; REVIEW; TOXICOLOGY; VIRUS INFECTION;

BIOLOGICAL MARKERS; BIOMARKERS, PHARMACOLOGICAL; CARDIOVASCULAR DISEASES; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; HUMANS; INDIVIDUALIZED MEDICINE; METABOLOMICS; NEOPLASMS; NERVOUS SYSTEM DISEASES;

EID: 77249159912     PISSN: 15571890     EISSN: 15571904     Source Type: Journal    
DOI: 10.1007/s11481-009-9156-4     Document Type: Review

References (113)

1. A Aharoni CH Ric de Vos HA Verhoeven CA Maliepaard G Kruppa R Bino DB Goodenowe 2002 Nontargeted metabolome analysis by use of Fourier transform ion cyclotron mass spectrometry OMICS 6 217 234 10.1089/15362310260256882 12427274
2. SN Akhtar RK Singh Y Jadegoud TN Dhole A Ayyagari GA Nagana Gowda 2007 In vitro (1) H NMR studies of RD human cell infection with echovirus 11 NMR Biomed 20 422 428 10.1002/nbm.1099 17013981 (Pubitemid 46824543)
3. P Appelblad T Jonsson W Jiang K Irgum 2008 Fast hydrophilic interaction liquid chromatographic separations on bonded zwitterionic stationary phase J Sep Sci 31 1529 1536 10.1002/jssc.200800080 18461573 (Pubitemid 351890780)
4. I Barba G de Leon E Martin A Cuevas S Aguade J Candell-Riera JA Barrabes D Garcia-Dorado 2008 Nuclear magnetic resonance-based metabolomics predicts exercise-induced ischemia in patients with suspected coronary artery disease Magn Reson Med 60 27 32 10.1002/mrm.21632 18581408 (Pubitemid 351956606)
5. RD Beger LK Schnackenberg RD Holland D Li Y Dragan 2006 Metabonomic models of human pancreatic cancer using 1D proton NMR spectra of lipids in plasma Metabolomics 2 125 134 10.1007/s11306-006-0026-2 (Pubitemid 44473571)
6. C Benecke R Grund R Hohberger A Kerber R Laue T Wieland 1995 Molgen(+), a generator of connectivity isomers and stereoisomers for molecular-structure elucidation Anal Chim Acta 314 141 147 10.1016/0003-2670(95)00291-7
7. HP Benton DM Wong SA Trauger G Siuzdak 2008 XCMS2: processing tandem mass spectrometry data for metabolite identification and structural characterization Anal Chem 80 6382 6389 10.1021/ac800795f 18627180
8. I Bertini A Calabro V De Carli C Luchinat S Nepi B Porfirio D Renzi E Saccenti L Tenori 2009 The metabonomic signature of celiac disease J Proteome Res 8 170 177 10.1021/pr800548z 19072164
9. M Bogdanov WR Matson L Wang T Matson R Saunders-Pullman SS Bressman M Flint Beal 2008 Metabolomic profiling to develop blood biomarkers for Parkinson's disease Brain 131 389 396 10.1093/brain/awm304 18222993 (Pubitemid 351197614)
10. JT Brindle H Antti E Holmes G Tranter JK Nicholson HW Bethell S Clarke PM Schofield E McKilligin DE Mosedale DJ Grainger 2002 Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics Nat Med 8 1439 1444 10.1038/nm802 12447357 (Pubitemid 36019430)
11. CD Broeckling IR Reddy AL Duran X Zhao LW Sumner 2006 MET-IDEA: data extraction tool for mass spectrometry-based metabolomics Anal Chem 78 4334 4341 10.1021/ac0521596 16808440
12. MA Burns W He CL Wu LL Cheng 2004 Quantitative pathology in tissue MR spectroscopy based human prostate metabolomics Technol Cancer Res Treat 3 591 598 15560717
13. EC Chan PK Koh M Mal PY Cheah KW Eu A Backshall R Cavill JK Nicholson HC Keun 2009 Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS) J Proteome Res 8 352 361 10.1021/pr8006232 19063642
14. C Chen KW Krausz JR Idle FJ Gonzalez 2008 Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice J Biol Chem 283 4543 4559 10.1074/jbc.M706299200 18093979
15. C Chen YM Shah K Morimura KW Krausz M Miyazaki TA Richardson ET Morgan JM Ntambi JR Idle FJ Gonzalez 2008 Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis Cell Metab 7 135 147 10.1016/j.cmet.2007.12.003 18249173 (Pubitemid 351168558)
16. J Chen SJ Swamidass Y Dou J Bruand P Baldi 2005 ChemDB: a public database of small molecules and related chemoinformatics resources Bioinformatics 21 4133 4139 10.1093/bioinformatics/bti683 16174682 (Pubitemid 41672103)
17. LL Cheng MA Burns JL Taylor W He EF Halpern WS McDougal CL Wu 2005 Metabolic characterization of human prostate cancer with tissue magnetic resonance spectroscopy Cancer Res 65 3030 3034 15833828
18. TA Clayton JC Lindon O Cloarec H Antti C Charuel G Hanton JP Provost JL Le Net D Baker RJ Walley JR Everett JK Nicholson 2006 Pharmaco-metabonomic phenotyping and personalized drug treatment Nature 440 1073 1077 10.1038/nature04648 16625200
19. CE Dalgliesh EC Horning MG Horning KL Knox K Yarger 1966 A gas-liquid-chromatographic procedure for separating a wide range of metabolites occurring in urine or tissue extracts Biochem J 101 792 810 16742460
20. C Denkert J Budczies T Kind W Weichert P Tablack J Sehouli S Niesporek D Konsgen M Dietel O Fiehn 2006 Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors Cancer Res 66 10795 10804 10.1158/0008-5472.CAN-06-0755 17108116 (Pubitemid 44876975)
21. C Denkert J Budczies W Weichert G Wohlgemuth M Scholz T Kind S Niesporek A Noske A Buckendahl M Dietel O Fiehn 2008 Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover Mol Cancer 7 72 10.1186/1476-4598-7-72 18799019
22. G Erb K Elbayed M Piotto J Raya A Neuville M Mohr D Maitrot P Kehrli IJ Namer 2008 Toward improved grading of malignancy in oligodendrogliomas using metabolomics Magn Reson Med 59 959 965 10.1002/mrm.21486 18429037 (Pubitemid 351590507)
23. O Fiehn J Kopka P Dormann T Altmann RN Trethewey L Willmitzer 2000 Metabolite profiling for plant functional genomics Nat Biotechnol 18 1157 1161 10.1038/81137 11062433 (Pubitemid 30823352)
24. ET Fossel JM Carr J McDonagh 1986 Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma N Engl J Med 315 1369 1376 3022146
25. A Frickenschmidt H Frohlich D Bullinger A Zell S Laufer CH Gleiter H Liebich B Kammerer 2008 Metabonomics in cancer diagnosis: mass spectrometry-based profiling of urinary nucleosides from breast cancer patients Biomarkers 13 435 449 10.1080/13547500802012858 18484357 (Pubitemid 351865818)
26. H Gao B Dong X Liu H Xuan Y Huang D Lin 2008 Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spectroscopy of human serum with multivariate data analysis Anal Chim Acta 624 269 277 10.1016/j.aca.2008.06.051 18706333
27. EP Go WR Wikoff Z Shen G O'Maille H Morita TP Conrads A Nordstrom SA Trauger W Uritboonthai DA Lucas KC Chan TD Veenstra H Lewicki MB Oldstone A Schneemann G Siuzdak 2006 Mass spectrometry reveals specific and global molecular transformations during viral infection J Proteome Res 5 2405 2416 10.1021/pr060215t 16944953 (Pubitemid 44330834)
28. G Graca IF Duarte BJG Carreira IM Couceiro AB Domingues R Mdo M Spraul LH Tseng AM Gil 2008 Metabolite profiling of human amniotic fluid by hyphenated nuclear magnetic resonance spectroscopy Anal Chem 80 6085 6092 10.1021/ac800907f 18564856
29. WJ Griffiths M Hornshaw G Woffendin SF Baker A Lockhart S Heidelberger M Gustafsson J Sjovall Y Wang 2008 Discovering oxysterols in plasma: a window on the metabolome J Proteome Res 7 3602 3612 10.1021/pr8001639 18605750
30. J Gullberg P Jonsson A Nordstrom M Sjostrom T Moritz 2004 Design of experiments: an efficient strategy to identify factors influencing extraction and derivatization of Arabidopsis thaliana samples in metabolomic studies with gas chromatography/mass spectrometry Anal Biochem 331 283 295 10.1016/j.ab.2004.04.037 15265734 (Pubitemid 38953079)
31. J Han RM Danell JR Patel DR Gumerov CO Scarlett JP Speir CE Parker I Rusyn S Zeisel CH Borchers 2008 Towards high-throughput metabolomics using ultrahigh-field Fourier transform ion cyclotron resonance mass spectrometry Metabolomics 4 128 140 10.1007/s11306-008-0104-8 19081807
32. R Hewer J Vorster FE Steffens D Meyer 2006 Applying biofluid 1H NMR-based metabonomic techniques to distinguish between HIV-1 positive/AIDS patients on antiretroviral treatment and HIV-1 negative individuals J Pharm Biomed Anal 41 1442 1446 10.1016/j.jpba.2006.03.006 16621406 (Pubitemid 43775905)
33. E Holmes RL Loo J Stamler M Bictash IK Yap Q Chan T Ebbels M De Iorio IJ Brown KA Veselkov ML Daviglus H Kesteloot H Ueshima L Zhao JK Nicholson P Elliott 2008 Human metabolic phenotype diversity and its association with diet and blood pressure Nature 453 396 400 10.1038/nature06882 18425110 (Pubitemid 351693125)
34. EC Horning MG Horning 1971 Metabolic profiles: gas-phase methods for analysis of metabolites Clin Chem 17 802 809 5105517
35. W Hosch T Junghanss M Stojkovic E Brunetti T Heye GW Kauffmann WE Hull 2008 Metabolic viability assessment of cystic echinococcosis using high-field 1H MRS of cyst contents NMR Biomed 21 734 754 10.1002/nbm.1252 18384178
36. HJ Issaq O Nativ T Waybright B Luke TD Veenstra EJ Issaq A Kravstov M Mullerad 2008 Detection of bladder cancer in human urine by metabolomic profiling using high performance liquid chromatography/mass spectrometry J Urol 179 2422 2426 10.1016/j.juro.2008.01.084 18433783
37. A Jacobs 2009 An FDA perspective on the nonclinical use of the X-Omics technologies and the safety of new drugs Toxicol Lett 186 1 32 35 18809476
38. P Jonsson AI Johansson J Gullberg J Trygg J A B Grung S Marklund M Sjostrom H Antti T Moritz 2005 High-throughput data analysis for detecting and identifying differences between samples in GC/MS-based metabolomic analyses Anal Chem 77 5635 5642 10.1021/ac050601e 16131076 (Pubitemid 41268639)
39. R Kaddurah-Daouk J McEvoy RA Baillie D Lee JK Yao PM Doraiswamy KR Krishnan 2007 Metabolomic mapping of atypical antipsychotic effects in schizophrenia Mol Psychiatry 12 934 945 10.1038/sj.mp.4002000 17440431 (Pubitemid 47482696)
40. J Kalisiak SA Trauger E Kalisiak H Morita VV Fokin MW Adams KB Sharpless G Siuzdak 2009 Identification of a new endogenous metabolite and the characterization of its protein interactions through an immobilization approach J Am Chem Soc 131 378 386 10.1021/ja808172n 19055353
41. A Kamleh MP Barrett D Wildridge RJ Burchmore RA Scheltema DG Watson 2008 Metabolomic profiling using Orbitrap Fourier transform mass spectrometry with hydrophilic interaction chromatography: a method with wide applicability to analysis of biomolecules Rapid Commun Mass Spectrom 22 1912 1918 10.1002/rcm.3564 18470888 (Pubitemid 351947757)
42. M Katajamaa M Oresic 2005 Processing methods for differential analysis of LC/MS profile data BMC Bioinformatics 6 179 10.1186/1471-2105-6-179 16026613 (Pubitemid 41372487)
43. M Katajamaa J Miettinen M Oresic 2006 MZmine: toolbox for processing and visualization of mass spectrometry based molecular profile data Bioinformatics 22 634 636 10.1093/bioinformatics/btk039 16403790 (Pubitemid 43372832)
44. H Kawashima M Oguchi H Ioi M Amaha G Yamanaka Y Kashiwagi K Takekuma Y Yamazaki A Hoshika Y Watanabe 2006 Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics Int J Neurosci 116 927 936 10.1080/00207450600550519 16861158 (Pubitemid 44154979)
45. K Kim P Aronov SO Zakharkin D Anderson B Perroud IM Thompson RH Weiss 2009 Urine metabolomic analysis for kidney cancer detection and biomarker discover Mol Cell Proteomics 8 558 570 19008263
46. GD Lewis R Wei E Liu E Yang X Shi M Martinovic L Farrell A Asnani M Cyrille A Ramanathan O Shaham G Berriz PA Lowry IF Palacios M Tasan FP Roth J Min C Baumgartner H Keshishian T Addona VK Mootha A Rosenzweig SA Carr MA Fifer MS Sabatine RE Gerszten 2008 Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury J Clin Invest 118 3503 3512 10.1172/JCI35111 18769631
47. H Lin J Zhang P Gao 2009 Silent myocardial ischemia is associated with altered plasma phospholipids J Clin Lab Anal 23 45 50 10.1002/jcla.20288 19140211
48. JC Lindon HC Keun TM Ebbels JM Pearce E Holmes JK Nicholson 2005 The Consortium for Metabonomic Toxicology (COMET): aims, activities and achievements Pharmacogenomics 6 691 699 10.2217/14622416.6.7.691 16207146 (Pubitemid 41479414)
49. NW Lutz A Viola I Malikova S Confort-Gouny B Audoin JP Ranjeva J Pelletier PJ Cozzone 2007 Inflammatory multiple-sclerosis plaques generate characteristic metabolic profiles in cerebrospinal fluid PLoS One 2 e595 10.1371/journal.pone.0000595 17611627 (Pubitemid 351260408)
50. H Lyng B Sitter TF Bathen LR Jensen K Sundfor GB Kristensen IS Gribbestad 2007 Metabolic mapping by use of high-resolution magic angle spinning 1H MR spectroscopy for assessment of apoptosis in cervical carcinomas BMC Cancer 7 11 10.1186/1471-2407-7-11 17233882 (Pubitemid 46210980)
51. Ma YL, Qin HL, Liu WJ, Peng JY, Huang L, Zhao XP, Cheng YY (2009) Ultra-high performance liquid chromatography-mass spectrometry for the metabolomic analysis of urine in colorectal cancer. Dig Dis Sci. doi: 10.1007/s10620-008-0665-4
52. D Monleon JM Morales A Barrasa JA Lopez C Vazquez B Celda 2009 Metabolite profiling of fecal water extracts from human colorectal cancer NMR Biomed 22 3 342 348 19006102
53. D Monleon JM Morales J Gonzalez-Darder F Talamantes O Cortes R Gil-Benso C Lopez-Gines M Cerda-Nicolas B Celda 2008 Benign and atypical meningioma metabolic signatures by high-resolution magic-angle spinning molecular profiling J Proteome Res 7 2882 2888 10.1021/pr800110a 18507434
54. D Morvan A Demidem 2007 Metabolomics by proton nuclear magnetic resonance spectroscopy of the response to chloroethylnitrosourea reveals drug efficacy and tumor adaptive metabolic pathways Cancer Res 67 2150 2159 10.1158/0008-5472.CAN-06-2346 17332345 (Pubitemid 46424234)
55. CE Mountford RL Somorjai P Malycha L Gluch C Lean P Russell B Barraclough D Gillett U Himmelreich B Dolenko AE Nikulin IC Smith 2001 Diagnosis and prognosis of breast cancer by magnetic resonance spectroscopy of fine-needle aspirates analysed using a statistical classification strategy Br J Surg 88 1234 1240 10.1046/j.0007-1323.2001.01864.x 11531873 (Pubitemid 34015609)
56. J Munger BD Bennett A Parikh XJ Feng J McArdle HA Rabitz T Shenk JD Rabinowitz 2008 Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy Nat Biotechnol 26 1179 1186 10.1038/nbt.1500 18820684
57. JK Nicholson MP O'Flynn PJ Sadler AF Macleod SM Juul PH Sonksen 1984 Proton-nuclear-magnetic-resonance studies of serum, plasma and urine from fasting normal and diabetic subjects Biochem J 217 365 375 6696735
58. JK Nicholson JC Lindon E Holmes 1999 'Metabonomics': understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data Xenobiotica 29 1181 1189 10.1080/004982599238047 10598751
59. F Nicoli J Vion-Dury S Confort-Gouny S Maillet JL Gastaut PJ Cozzone 1996 Cerebrospinal fluid metabolic profiles in multiple sclerosis and degenerative dementias obtained by high resolution proton magnetic resonance spectroscopy C R Acad Sci III 319 623 631 9011324
60. A Nordstrom G O'Maille C Qin G Siuzdak 2006 Nonlinear data alignment for UPLC-MS and HPLC-MS based metabolomics: quantitative analysis of endogenous and exogenous metabolites in human serum Anal Chem 78 3289 3295 10.1021/ac060245f 16689529 (Pubitemid 43748971)
61. A Nordstrom E Want T Northen J Lehtio G Siuzdak 2008 Multiple ionization mass spectrometry strategy used to reveal the complexity of metabolomics Anal Chem 80 421 429 10.1021/ac701982e 18085752
62. TR Northen O Yanes MT Northen D Marrinucci W Uritboonthai J Apon SL Golledge A Nordstrom G Siuzdak 2007 Clathrate nanostructures for mass spectrometry Nature 449 1033 1036 10.1038/nature06195 17960240 (Pubitemid 350017585)
63. G O'Maille EP Go L Hoang EJ Want C Smith P O'Maille A Nordstrom H Morita C Qin W Uritboonthai J Apon R Moore J Garrett G Siuzdak 2008 Metabolomics relative quantitation with mass spectrometry using chemical derivatization and isotope labeling Spectr Int J 22 327 343
64. K Odunsi RM Wollman CB Ambrosone A Hutson SE McCann J Tammela JP Geisler G Miller T Sellers W Cliby F Qian B Keitz M Intengan S Lele JL Alderfer 2005 Detection of epithelial ovarian cancer using 1H-NMR-based metabonomics Int J Cancer 113 782 788 10.1002/ijc.20651 15499633 (Pubitemid 40101260)
65. SG Oliver MK Winson DB Kell F Baganz 1998 Systematic functional analysis of the yeast genome Trends Biotechnol 16 373 378 10.1016/S0167-7799(98)01214-1 9744112 (Pubitemid 28410425)
66. M Osl S Dreiseitl B Pfeifer K Weinberger H Klocker G Bartsch G Schafer B Tilg A Graber C Baumgartner 2008 A new rule-based algorithm for identifying metabolic markers in prostate cancer using tandem mass spectrometry Bioinformatics 24 2908 2914 10.1093/bioinformatics/btn506 18815183
67. R Pandher C Ducruix SA Eccles FI Raynaud 2008 Cross-platform Q-TOF validation of global exo-metabolomic analysis: application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002 J Chromatogr B Analyt Technol Biomed Life Sci 877 13 1352 1358 19101213
68. AD Patterson H Li GS Eichler KW Krausz JN Weinstein AJ Fornace Jr FJ Gonzalez JR Idle 2008 UPLC-ESI-TOFMS-based metabolomics and gene expression dynamics inspector self-organizing metabolomic maps as tools for understanding the cellular response to ionizing radiation Anal Chem 80 665 674 10.1021/ac701807v 18173289 (Pubitemid 351206854)
69. L Pauling AB Robinson R Teranishi P Cary 1971 Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography Proc Natl Acad Sci USA 68 2374 2376 10.1073/pnas.68.10.2374 5289873
70. G Pendyala EJ Want W Webb G Siuzdak HS Fox 2007 Biomarkers for neuroAIDS: the widening scope of metabolomics J Neuroimmune Pharmacol 2 72 80 10.1007/s11481-006-9041-3 18040828
71. B Perroud J Lee N Valkova A Dhirapong PY Lin O Fiehn D Kultz RH Weiss 2006 Pathway analysis of kidney cancer using proteomics and metabolic profiling Mol Cancer 5 64 10.1186/1476-4598-5-64 17123452 (Pubitemid 44941442)
72. M Phillips K Gleeson JM Hughes J Greenberg RN Cataneo L Baker WP McVay 1999 Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study Lancet 353 1930 1933 10.1016/S0140-6736(98)07552-7 10371572 (Pubitemid 29255706)
73. M Phillips N Altorki JH Austin RB Cameron RN Cataneo J Greenberg R Kloss RA Maxfield MI Munawar HI Pass A Rashid WN Rom P Schmitt 2007 Prediction of lung cancer using volatile biomarkers in breath Cancer Biomarkers 3 95 109 17522431
74. R Plumb J Castro-Perez J Granger I Beattie K Joncour A Wright 2004 Ultra-performance liquid chromatography coupled to quadrupole-orthogonal time-of-flight mass spectrometry Rapid Commun Mass Spectrom 18 2331 2337 10.1002/rcm.1627 15384155 (Pubitemid 39297371)
75. D Poli P Carbognani M Corradi M Goldoni O Acampa B Balbi L Bianchi M Rusca A Mutti 2005 Exhaled volatile organic compounds in patients with non-small cell lung cancer: cross sectional and nested short-term follow-up study Respir Res 6 71 10.1186/1465-9921-6-71 16018807 (Pubitemid 41410164)
76. LM Raamsdonk B Teusink D Broadhurst N Zhang A Hayes MC Walsh JA Berden KM Brindle DB Kell JJ Rowland HV Westerhoff K van Dam SG Oliver 2001 A functional genomics strategy that uses metabolome data to reveal the phenotype of silent mutations Nat Biotechnol 19 45 50 10.1038/83496 11135551 (Pubitemid 32051955)
77. AD Richardson C Yang A Osterman JW Smith 2008 Central carbon metabolism in the progression of mammary carcinoma Breast Cancer Res Treat 110 297 307 10.1007/s10549-007-9732-3 17879159 (Pubitemid 351793887)
78. S Rozen ME Cudkowicz M Bogdanov WR Matson BS Kristal C Beecher S Harrison P Vouros J Flarakos K Vigneau-Callahan TD Matson KM Newhall MF Beal RH Brown R Kaddurah-Daouk 2005 Metabolomic analysis and signatures in motor neuron disease Metabolomics 1 101 108 10.1007/s11306-005-4810-1 18820733 (Pubitemid 40778831)
79. MS Sabatine E Liu DA Morrow E Heller R McCarroll R Wiegand GF Berriz FP Roth RE Gerszten 2005 Metabolomic identification of novel biomarkers of myocardial ischemia Circulation 112 3868 3875 10.1161/CIRCULATIONAHA.105.569137 16344383 (Pubitemid 43739484)
80. TR Sana K Waddell SM Fischer 2008 A sample extraction and chromatographic strategy for increasing LC/MS detection coverage of the erythrocyte metabolome J Chromatogr B Analyt Technol Biomed Life Sci 871 314 321 10.1016/j.jchromb. 2008.04.030 18495560
81. Scholz M, Fiehn O (2007) Setup X-a public study design database for metabolomic projects. 13th Pacific Symposium on Biocomputing (PSB), Maui, HI, World Scientific Publ Co Pte Ltd.
82. MR Shortreed SM Lamos BL Frey MF Phillips M Patel PJ Belshaw LM Smith 2006 Ionizable isotopic labeling reagent for relative quantification of amine metabolites by mass spectrometry Anal Chem 78 6398 6403 10.1021/ac0607008 16970314 (Pubitemid 44413590)
83. IL Simone F Federico M Trojano C Tortorella M Liguori P Giannini E Picciola G Natile P Livrea 1996 High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques J Neurol Sci 144 182 190 10.1016/S0022-510X(96)00224-9 8994122 (Pubitemid 27019176)
84. CM Slupsky KN Rankin J Wagner H Fu D Chang AM Weljie EJ Saude B Lix DJ Adamko S Shah R Greiner BD Sykes TJ Marrie 2007 Investigations of the effects of gender, diurnal variation, and age in human urinary metabolomic profiles Anal Chem 79 6995 7004 10.1021/ac0708588 17702530 (Pubitemid 47438678)
85. CA Smith G O'Maille EJ Want C Qin SA Trauger TR Brandon DE Custodio R Abagyan G Siuzdak 2005 METLIN: a metabolite mass spectral database Ther Drug Monit 27 747 751 10.1097/01.ftd.0000179845.53213.39 16404815 (Pubitemid 44391729)
86. CA Smith EJ Want G O'Maille R Abagyan G Siuzdak 2006 XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification Anal Chem 78 779 787 10.1021/ac051437y 16448051 (Pubitemid 43228585)
87. SE Stein 1999 An integrated method for spectrum extraction and compound identification from gas chromatography/mass spectrometry data J Am Soc Mass Spectrom 10 770 781 10.1016/S1044-0305(99)00047-1 (Pubitemid 34506228)
88. R Tautenhahn C Bottcher S Neumann 2008 Highly sensitive feature detection for high resolution LC/MS BMC Bioinformatics 9 504 10.1186/1471-2105-9-504 19040729
89. R T'Kindt M Storme D Deforce J Van Bocxlaer 2008 Evaluation of hydrophilic interaction chromatography versus reversed-phase chromatography in a plant metabolomics perspective J Sep Sci 31 1609 1614 10.1002/jssc.200700539 18428188 (Pubitemid 351890788)
90. VV Tolstikov O Fiehn 2002 Analysis of highly polar compounds of plant origin: combination of hydrophilic interaction chromatography and electrospray ion trap mass spectrometry Anal Biochem 301 298 307 10.1006/abio.2001.5513 11814300 (Pubitemid 34158194)
91. AA Tzika L Astrakas H Cao D Mintzopoulos OC Andronesi M Mindrinos J Zhang LG Rahme KD Blekas AC Likas NP Galatsanos RS Carroll PM Black 2007 Combination of high-resolution magic angle spinning proton magnetic resonance spectroscopy and microscale genomics to type brain tumor biopsies Int J Mol Med 20 199 208 17611638
92. BR Underwood D Broadhurst WB Dunn DI Ellis AW Michell C Vacher DE Mosedale DB Kell RA Barker DJ Grainger DC Rubinsztein 2006 Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles Brain 129 877 886 10.1093/brain/awl027 16464959
93. S Vaidyanathan S Gaskell R Goodacre 2006 Matrix-suppressed laser desorption/ionisation mass spectrometry and its suitability for metabolome analyses Rapid Commun Mass Spectrom 20 1192 1198 10.1002/rcm.2434 16541414
94. RA van den Berg HC Hoefsloot JA Westerhuis AK Smilde MJ van der Werf 2006 Centering, scaling, and transformations: improving the biological information content of metabolomics data BMC Genomics 7 142 10.1186/1471-2164-7-142 16762068 (Pubitemid 44202795)
95. MJ van der Werf KM Overkamp B Muilwijk L Coulier T Hankemeier 2007 Microbial metabolomics: toward a platform with full metabolome coverage Anal Biochem 370 17 25 10.1016/j.ab.2007.07.022 17765195 (Pubitemid 47404495)
96. MC Walsh L Brennan JP Malthouse HM Roche MJ Gibney 2006 Effect of acute dietary standardization on the urinary, plasma, and salivary metabolomic profiles of healthy humans Am J Clin Nutr 84 531 539 16960166
97. JN Wang Y Zhou TY Zhu X Wang YL Guo 2008 Prediction of acute cellular renal allograft rejection by urinary metabolomics using MALDI-FTMS J Proteome Res 7 3597 3601 10.1021/pr800092f 18620448
98. EJ Want G O'Maille CA Smith TR Brandon W Uritboonthai C Qin SA Trauger G Siuzdak 2006 Solvent-dependent metabolite distribution, clustering, and protein extraction for serum profiling with mass spectrometry Anal Chem 78 743 752 10.1021/ac051312t 16448047 (Pubitemid 43228581)
99. EJ Want CA Smith CA Qin KC VanHorne G Siuzdak 2006 Phospholipid capture combined with non-linear chromatographic correction for improved serum metabolite profiling Metabolomics 2 145 154 10.1007/s11306-006-0028-0 (Pubitemid 44473573)
100. SM Watkins PR Reifsnyder HJ Pan JB German EH Leiter 2002 Lipid metabolome-wide effects of the PPARgamma agonist rosiglitazone J Lipid Res 43 1809 1817 10.1194/jlr.M200169-JLR200 12401879 (Pubitemid 35315798)
101. E Werner V Croixmarie T Umbdenstock E Ezan P Chaminade JC Tabet C Junot 2008 Mass spectrometry-based metabolomics: accelerating the characterization of discriminating signals by combining statistical correlations and ultrahigh resolution Anal Chem 80 4918 4932 10.1021/ac800094p 18512947 (Pubitemid 351956299)
102. WR Wikoff JA Gangoiti BA Barshop G Siuzdak 2007 Metabolomics identifies perturbations in human disorders of propionate metabolism Clin Chem 53 2169 2176 10.1373/clinchem.2007.089011 17951291 (Pubitemid 350197301)
103. WR Wikoff G Pendyala G Siuzdak HS Fox 2008 Metabolomic analysis of the cerebrospinal fluid reveals changes in phospholipase expression in the CNS of SIV-infected macaques J Clin Invest 118 2661 2669 10.1172/JCI34138 18521184
104. JM Wiseman SM Puolitaival Z Takats RG Cooks RM Caprioli 2005 Mass spectrometric profiling of intact biological tissue by using desorption electrospray ionization Angew Chem Int Ed Engl 44 7094 7097 10.1002/anie. 200502362 16259018 (Pubitemid 41587581)
105. DS Wishart C Knox AC Guo R Eisner N Young B Gautam DD Hau N Psychogios E Dong S Bouatra R Mandal I Sinelnikov J Xia L Jia JA Cruz E Lim CA Sobsey S Shrivastava P Huang P Liu L Fang J Peng R Fradette D Cheng D Tzur M Clements A Lewis A De Souza A Zuniga M Dawe Y Xiong D Clive R Greiner A Nazyrova R Shaykhutdinov L Li HJ Vogel I Forsythe 2009 HMDB: a knowledgebase for the human metabolome Nucleic Acids Res 37 D603 D610 10.1093/nar/gkn810 18953024
106. HM Woo KM Kim MH Choi BH Jung J Lee G Kong SJ Nam S Kim SW Bai BC Chung 2009 Mass spectrometry based metabolomic approaches in urinary biomarker study of women's cancers Clin Chim Acta 400 63 69 10.1016/j.cca.2008.10.014 19010317
107. J Woodcock R Woosley 2008 The FDA critical path initiative and its influence on new drug development Annu Rev Med 59 1 12 10.1146/annurev.med.59. 090506.155819 18186700 (Pubitemid 351287920)
108. Y Xu L Du MJ Rose I Fu EJ Woolf DG Musson 2005 Concerns in the development of an assay for determination of a highly conjugated adsorption-prone compound in human urine J Chromatogr B Analyt Technol Biomed Life Sci 818 241 248 10.1016/j.jchromb.2005.01.004 15734165 (Pubitemid 40331830)
109. SK Yan BJ Wei ZY Lin Y Yang ZT Zhou WD Zhang 2008 A metabonomic approach to the diagnosis of oral squamous cell carcinoma, oral lichen planus and oral leukoplakia Oral Oncol 44 477 483 10.1016/j.oraloncology.2007.06.007 17936673 (Pubitemid 351608618)
110. C Yang AD Richardson JW Smith A Osterman 2007 Comparative metabolomics of breast cancer Pac Symp Biocomput 12 181 192 10.1142/9789812772435-0018
111. J Yang G Xu Y Zheng H Kong T Pang S Lv Q Yang 2004 Diagnosis of liver cancer using HPLC-based metabonomics avoiding false-positive result from hepatitis and hepatocirrhosis diseases J Chromatogr B Analyt Technol Biomed Life Sci 813 59 65 10.1016/j.jchromb.2004.09.032 15556516 (Pubitemid 39535429)
112. K Yu G Sheng J Sheng Y Chen W Xu X Liu H Cao H Qu Y Cheng L Li 2007 A metabonomic investigation on the biochemical perturbation in liver failure patients caused by hepatitis B virus J Proteome Res 6 2413 2419 10.1021/pr060591d 17539670 (Pubitemid 47122338)
113. Y Zhen KW Krausz C Chen JR Idle FJ Gonzalez 2007 Metabolomic and genetic analysis of biomarkers for peroxisome proliferator-activated receptor alpha expression and activation Mol Endocrinol 21 2136 2151 10.1210/me.2007-0150 17550978 (Pubitemid 47347378)